GRAIL, Inc. (GRAL)
104.65
+2.68
(+2.63%)
USD |
NASDAQ |
Jan 14, 16:00
103.91
-0.74
(-0.71%)
After-Hours: 20:00
GRAIL EPS Diluted (Quarterly): -2.463 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Thermo Fisher Scientific, Inc. | 4.275 |
| FONAR Corp. | 0.3368 |
| XWELL, Inc. | -0.2557 |
| ProPhase Labs, Inc. | -1.646 |
| Veracyte, Inc. | 0.2401 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -88.98M |
| Revenue (Quarterly) | 36.19M |
| Total Expenses (Quarterly) | 125.17M |
| Enterprise Value | 3.493B |
| Gross Profit Margin (Quarterly) | -47.91% |
| Profit Margin (Quarterly) | -245.8% |
| Earnings Yield | -11.09% |
| Normalized Earnings Yield | -10.58 |